SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013628
Filing Date
2018-05-15
Accepted
2018-05-15 16:06:41
Documents
50
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20180331.htm 10-Q 1326669
2 EX-10.1 life-ex101_149.htm EX-10.1 47716
3 EX-31.1 life-ex311_10.htm EX-31.1 9626
4 EX-31.2 life-ex312_350.htm EX-31.2 9137
5 EX-32.1 life-ex321_7.htm EX-32.1 5500
6 EX-32.2 life-ex322_9.htm EX-32.2 5513
7 GRAPHIC g201805151846459975085.jpg GRAPHIC 7804
  Complete submission text file 0001564590-18-013628.txt   5246527

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT life-20180331.xml EX-101.INS 1217654
9 XBRL TAXONOMY EXTENSION SCHEMA life-20180331.xsd EX-101.SCH 38674
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20180331_cal.xml EX-101.CAL 35490
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20180331_def.xml EX-101.DEF 155162
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20180331_lab.xml EX-101.LAB 305572
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20180331_pre.xml EX-101.PRE 233973
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 18836416
SIC: 2836 Biological Products, (No Diagnostic Substances)